The University of Chicago Header Logo

Connection

Andrzej Jakubowiak to Germany

Back to Details
This is a "connection" page, showing publications Andrzej Jakubowiak has written about Germany.
Andrzej Jakubowiak
Connection Strength
0.033
Germany
  1. Elotuzumab in combination with lenalidomide and dexamethasone in patients with relapsed multiple myeloma: final phase 2 results from the randomised, open-label, phase 1b-2 dose-escalation study. Lancet Haematol. 2015 Dec; 2(12):e516-27.
    View in: PubMed
    Score: 0.033
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.